Cable Viewer

Currently released so far... 12856 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01 1988/03 1988/07
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1996/07 1996/11
1997/06 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AVERY AMGT AR ASEC AMED AORC AG AU AM APEC ABUD AF AS AGRICULTURE AEMR ASEAN APECO ACOA AJ AO AFIN ABLD ADPM AY ASCH AE AFFAIRS AA AC ARF APER AFU AINF AODE AMG ATPDEA AGAO ASECKFRDCVISKIRFPHUMSMIGEG AID AL AORL AFSI AFSN ADCO ASUP AN AIT ANET ASIG AGMT ADANA AADP ACS AGR AMCHAMS AECL AUC AFGHANISTAN ADM ACAO AND ATRN ALOW APCS AORG AROC ACABQ AX AMEX AZ ARM AQ ATFN AMBASSADOR ACBAQ ASEX AER
BR BA BO BL BK BT BD BU BBSR BMGT BM BY BX BTIO BEXP BG BB BH BF BP BWC BRUSSELS BN BTIU BIDEN BE BILAT BC
CA CS CASC CO CI CD CH CN CY CONDOLEEZZA CU CE CVIS CG CMGT CF CPAS CDC CW CJAN CJUS CTM CM CFED CODEL CWC CR CBW CAN CLMT CBC CONS COUNTERTERRORISM CIA CDG CIC COUNTER CT CNARC CACM CB CV CIDA CLINTON CHR COE CIS CBSA CEUDA CAC CL CACS CAPC CTR COM CROS CARSON COPUOS CICTE CYPRUS COUNTRY CBE CKGR CVR CITEL CLEARANCE CARICOM CSW CITT CDB
DA DR DTRA DEA DHS DJ DO DEAX DAO DCM DE DOD DOMESTIC DK DPRK DEPT DISENGAGEMENT DOE DS DEFENSE
EUN ECON ELAB ETRD EFIN ECIN EAGR EAIR EN EG ECA ET ER EWWT EIND EINV EAID EC EU EFIS ETTC EPET ENRG EMIN ECPS ENGR EINVETC ELTN ECONCS EZ ES EI ECONOMIC ELN EINT EPA ETRA EXTERNAL ESA ETRDEINVECINPGOVCS EAIG EUR EK EUMEM EUREM EUC ENERG ERD EFTA ETRC ETRN EINVECONSENVCSJA EEPET EUNCH ESENV ENNP ENVI ECINECONCS ELECTIONS ENVR ENIV ETRO ETRDECONWTOCS ECUN EXIM EFINECONCS ECONOMY ERNG EINVEFIN ETC EAP EINN EXBS ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EAIDS EREL
FI FR FTA FTAA FBI FAC FJ FM FDA FARC FAO FO FOR FMLN FISO FAS FREEDOM FOREIGN FINANCE FINR FOI
GV GA GG GE GM GH GTIP GT GZ GAERC GR GOI GCC GOV GY GANGS GERARD GTMO GL GF GAZA GLOBAL
HK HUMAN HA HO HR HU HURI HILLARY HYMPSK HSTC HEBRON HUMOR HI
IV IS IC IIP IR ICRC IZ IWC IAEA IT IN IRS ICAO IQ IMO ILC IMF ILO IF ITPHUM IL IO ID ISRAEL IACI INMARSAT IPR ICTY ICJ INDO IA IDA IBRD IAHRC ISLAMISTS IGAD ITU ITF INRA INRO INRB ITALY IBET INTELSAT ISRAELI IDP ICTR ITRA IRC IRAQI IEFIN ITPGOV ITALIAN INTERNAL INTERPOL IEA INR IZPREL IRAJ
JA JP JO JM JOSEPH JUS JAMES JOHN JOHNNIE
KPAO KV KGIT KPAL KDEM KCRM KISL KPKO KSCA KOMC KTFN KNNP KN KZ KIPR KE KCIP KWMN KGIC KTIA KFRD KHDP KSEP KMPI KG KIRF KJUS KWBG KHLS KCOR KMDR KU KTDB KTIP KS KFLU KGHG KRAD KSPR KHIV KCOM KAID KOM KUNR KRVC KICC KBTS KSUM KOLY KAWC KIRC KDRG KCRS KNPP KSTH KWNM KRFD KVIR KLIG KFLO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KVPR KTEX KTER KRGY KCFE KIDE KSTC KREC KR KPAONZ KIFR KOCI KBTR KBIO KMCA KGCC KACT KMRS KAWK KSAC KWMNCS KNEI KPOA KSEO KFIN KWAC KNAR KPLS KPAK KSCI KPRP KOMS KBCT KPWR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KRIM KDDG KPRV KSAF KCGC KPAI KFSC KMFO KID KMIG KVRP KNSD KMOC KTBT KENV KCMR KWMM KHSA KO KX KCRCM KNUP KNUC KNNPMNUC KERG KTLA KCSY KTRD KJUST KRCM KCFC KCHG KREL KFTFN KDEMAF KICA KHUM KSEC KPIN KESS KDEV KWWMN
LY LE LH LABOR LI LG LO LA LU LOG LTTE LAB LT
MARR MOPS MO MASS MX MA MR MNUC MCAP MAPS MD MV MTCRE MY MP ML MILITARY MEPN MARAD MDC MU MEPP MIL MAPP MZ MT MASSMNUC MK MTCR MUCN MAS MEDIA MAR MI MQADHAFI MPOS MG MPS MW MC MTRE MRCRE MASC MOPPS MTS MLS MILI MEPI MEETINGS MERCOSUR MCC MIK
NATO NL NI NZ NG NO NP NK NU NDP NPT NSF NR NAFTA NATOPREL NS NEW NA NE NSSP NSC NH NV NPA NSFO NT NW NASA NSG NORAD NATIONAL NPG NGO NIPP NZUS NC NRR NAR
OEXC OVIP OTRA ODIP OFDP OPDC OPIC OIIP OPRC OAS OREP OSCE OECD OPCW OSCI OMIG OVP OIE ON OCII OPAD OBSP OFFICIALS OES OCS OIC OHUM OTR OSAC OFDA
PTER PREL PE PHUM PGOV PARM PINR PREF PINS PBTS PA PK PM PL PO POL PROP PSOE PHSA PAK PY PLN PMAR PHUH PBIO PF PHUS PTBS PU PNAT POLITICAL PARTIES PCUL PGGV PAO PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PAS PGIV PHUMPREL POGOV PEL PP PINL PBT PG PINF PRL PALESTINIAN PSEPC POSTS PAHO PROV PHUMPGOV POV PGOC PNR PREFA PMIL PREO POLITICS POLICY PDOV PCI PRAM PSI PAIGH PJUS PARMS PROG PTERE PRGOV PORG PS PGOF PKFK PEPR PPA PINT PRELP PNG PFOR PUNE PGOVLO PHUMBA POLINT PGOVE PHALANAGE PARTY PDEM PECON
QA
RS RU RW RIGHTSPOLMIL RICE RUPREL RIGHTS RO RF RELATIONS RP RM RFE REGION REACTION REPORT RCMP RSO ROOD ROBERT RSP
SCUL SNAR SP SENV SU SO SMIG SOCI SW SA SZ SY SL SENVKGHG SF SR SN SARS SANC SHI SIPDIS SEVN SHUM SC SI STEINBERG SK SH SNARCS SPCE SNARN SG SYRIA SNARIZ SWE SIPRS SYR SAARC SEN SCRS SAN ST SSA SPCVIS SOFA
TSPL TBIO TU TH TP TRGY TPHY TZ TW TX TSPA TFIN TC TI TS TAGS TK TIP TNGD TL TV TT TINT TERRORISM TR TN TD TBID TF THPY TO TRSY TURKEY
UN UNSC UK US UNGA UNDP UP UG USTR UNHRC UY UNESCO UNMIK UNEP UZ UNO UNHCR USEU UNAUS UNCHR UNPUOS UNDC UNICEF UNCHC UNCSD USOAS UNFCYP UNIDROIT UV UNCND USUN USNC USPS USAID UE UNVIE UAE UNODC UNCHS UNFICYP UNDESCO UNC
VZ VM VE VT VAT VC VI VTPREL VN VTIZ VTEG
WS WHA WHO WTRO WIPO WEU WZ WTO WMO WA WWARD WHTI WTRQ WBG WFP WB WI WMD WITH
XA XR XM XG XW XB XV XF XD XS XK XY XC XL XZ XX XU XI XT XH XQ XE XTAG
YI YM YE YMCS
ZI ZF ZU ZR ZK ZANU ZB ZEALAND ZP ZO ZL ZOELLICK ZJ ZN ZA

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`